Prognostic and Predictive Value of Cadherin 11 for Patients with Gastric Cancer and Its Correlation with Tumor Microenvironment: Results from Microarray Analysis

Biomed Res Int. 2020 Jun 26:2020:8107478. doi: 10.1155/2020/8107478. eCollection 2020.

Abstract

Gastric cancer is a disease characterized by inflammation, and epithelial-to-mesenchymal transition (EMT) and tumor-associated macrophages (TAMs) both play a vital role in epithelial-driven malignancy. In the present study, we performed an integrated bioinformatics analysis of transcriptome data from multiple databases of gastric cancer patients and worked on a biomarker for evaluating tumor prognosis. We found that cadherin 11 (CDH11) is highly expressed not only in gastric cancer tissues but also in EMT molecular subtypes and metastatic patients. Also, we obtained evidence that CDH11 has a significant correlation with infiltrating immune cells in the tumor microenvironment (TME). Our findings reflected that CDH11 likely plays an important role in tumor immune escape and could provide a prognostic biomarker and potential therapeutic target for patients with gastric cancer.

MeSH terms

  • Cadherins / biosynthesis*
  • Cadherins / genetics
  • Epithelial-Mesenchymal Transition*
  • Female
  • Gene Expression Profiling
  • Humans
  • Male
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / genetics
  • Oligonucleotide Array Sequence Analysis*
  • Prognosis
  • Stomach Neoplasms / diagnosis
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / metabolism*
  • Tumor Microenvironment*

Substances

  • Cadherins
  • Neoplasm Proteins
  • osteoblast cadherin